Pier 88 Investment Partners LLC Mirati Therapeutics, Inc. Transaction History

Pier 88 Investment Partners LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$27.8 - $45.35 $237,690 - $387,742	8,550 Added 108.37%	16,440 $716,000
Q2 2023 Aug 07, 2023	BUY	$36.13 - $49.49 $16,258 - $22,270	450 Added 6.05%	7,890 $285,000
Q1 2023 May 09, 2023	BUY	$36.54 - $54.26 $122,409 - $181,771	3,350 Added 81.91%	7,440 $276,000
Q4 2022 Feb 08, 2023	SELL	$41.27 - $98.62 $219,143 - $523,672	-5,310 Reduced 56.49%	4,090 $185,000
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $116,620 - $169,932	-1,960 Reduced 17.25%	9,400 $656,000

Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $280,385 - $635,163	7,160 Added 170.48%	11,360 $763,000
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $66,005 - $95,145	500 Added 13.51%	4,200 $616,000
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $439,992 - $590,908	3,330 Added 900.0%	3,700 $654,000
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $427,680 - $533,798	-2,970 Reduced 88.92%	370 $60,000
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $17,825 - $26,429	110 Added 3.41%	3,340 $2.52 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $365,829 - $540,282	3,230 New	3,230 $536,000
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $414,057 - $692,242	-5,750 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $251,208 - $418,356	3,600 Added 167.44%	5,750 $442,000
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $152,134 - $277,049	2,150 New	2,150 $277,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Pier 88 Investment Partners LLC with notifications on news.